Rammohan, Kottil W <br/><br/>
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.  [electronic resource] 

 -  Neurology  Nov 2011 
 - 1930; discussion 1930-1 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/WNL.0b013e31823c1200  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy